As of Jul 14, 2025, Rapport Therapeutics Inc. Common Stock has 11,740 shares failed to deliver, representing 6.31% of the average daily volume of 185,961 shares. Over the past year, the monthly average FTD is 4,210 shares, with the current level 179% above the historical average, indicating elevated settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.